← Evidence map

Observational studyJournal of the American Heart Association2022

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.

Shengyuan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 35924778